Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373

Nephrology

A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Condition:   Primary Focal Segmental Glomerulosclerosis
Intervention:   Drug: CXA-10
Sponsors:   Complexa, Inc.;   NephCure Accelerating Cures Institute;   Medpace, Inc.;   MicroConstants;   Arkana Labs;   NephCure Kidney International
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 7, 2018 / by / in
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn’s Disease

Conditions:   Ulcerative Colitis;   Crohn’s Disease
Intervention:   Drug: Etrolizumab
Sponsor:   Hoffmann-La Roche
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 27, 2018 / by / in
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases – PHOENIX

Conditions:   IgA Nephropathy;   CKD Associated With Type 1 Diabetes;   Focal Segmental Glomerulosclerosis;   Autosomal Dominant Polycystic Kidney
Intervention:   Drug: Bardoxolone methyl capsules
Sponsor:   Reata Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

December 28, 2017 / by / in